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Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France, 4 Department of Clinical and Experimental
Medicine, Brighton and Sussex Medical School, Brighton, United Kingdom, 5 Institute for Transfusion Medicine and
Transplant Engineering, Hannover Medical School, Hannover, Germany, 6 Immunology and Allergy Group, Maimonides
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The impact of biological sex on T-cell immunity to Cytomegalovirus (CMV) has not been
investigated in detail with only one published study comparing CMV-specific T-cell
responses in men and women. Many studies, however, have shown an association
between CMV infection and immunosenescence, with broad effects on peripheral blood
lymphocyte subsets as well as the T and B-cell repertoires. Here, we provide a detailed
analysis of CMV-specific T-cell responses in (n=94) CMV+ older people, including 47
women and 47 men aged between 60 and 93 years. We explore sex differences with
respect to 16 different CMV proteins arranged in 14 peptide pools (overlapping peptides).
Following ex vivo stimulation, CD4 and CD8 T-cells producing IFN-g, TNF, and IL-2 were
enumerated by flow-cytometry (intracellular cytokine staining). T-cell responses were
evaluated in terms of each cytokine separately or in terms of cytokines produced
simultaneously (polyfunctionality). Surface memory phenotype and CD3 downmodulation
were assessed in parallel. The polyfunctionality index and a memory subset differentiation
score were used to identify associations between response size, cytokine production,
polyfunctionality, and memory subset distribution. While no significant sex differences were
found with respect to overall CMV target protein selection, the T-cell response in men
appeared more focused and accompanied by a more prominent accumulation of CMV-
specific memory CD4 and CD8 T-cells. T-cell polyfunctionality and differentiation were similar
in the sexes, however, CMV-specific T-cells in men produced more pro-inflammatory
cytokines. Particularly, TNF production by CD4 T-cells was stronger in men than in
women. Also, compared with women, men had larger responses to CMV proteins with
immediate-early/early kinetics than women, which might have been driven by CMV
reactivation. In conclusion, the CMV-specific T-cell response in men was larger and moreorg August 2021 | Volume 12 | Article 7078301
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Frontiers in Immunology | www.frontiersin.pro-inflammatory than in women. Our findings may help explain sex differences in CMV-
associated pathologies.Keywords: aging, T cell, Cytomegalovirus (CMV), immunosenescence, biological sexINTRODUCTION
Cytomegalovirus (CMV) infection has a major impact on the
immune system, in particular on the distribution of lymphocyte
subsets (1, 2). CMV prevalence increases with age, which also has
a profound effect on the immune system by reducing its ability to
respond to infection and cancer (immunosenescence). This
CMV prevalence results in increased morbidity and mortality
in older people. Biological sex appears to modify both the effect
of CMV infection and aging (3–6). It is important to note that
immunosenescence also occurs in the absence of CMV infection,
however, changes resulting from CMV infection may accelerate
the effects of immunosenescence.
A role of CMV infection in immunosenescence has been
supported by numerous publications since the early 2000s. Loss
of the costimulatory molecule CD28 on CD4 T-cells (generating
‘CD28null CD4 T-cells’) has been recognized as a hallmark of
immune ageing since 1999 (7) and for just as long, it has been
clear that CMV is associated with its occurrence (8). This
culminated in the hypothesis that immunosenescence may be
‘infectious’ (9). Our own recent work (10) has clarified that
CD28null CD4 T-cells do not increase with age among CMV-
seronegative (CMV-) people showing that accumulation of these
cells is not related to aging per se. So, aging and immune aging
are not the same thing, they just coincide in older people.
CD28null CD4 T-cells clearly have features of ‘aged’ immune
cells (e.g., replicative senescence) and the immune system of
people with expanded CD28null CD4 T-cells would, therefore,
appear more aged. Since older people tend to be more frequently
CMV-seropositive (CMV+) than younger individuals, the effects
of aging and CMV cannot be easily differentiated in the elderly.
CMV prevalence can be up to 90% or more in many parts of the
world (11).
CMV has been implicated in memory T-cell inflation, in
particular in mouse models (12), and in a number of conditions
associated with changes to the peripheral blood T-cell
compartment, including autoimmune disease, atherosclerosis,
and cardiovascular disease (CVD). CVD is not only more
common in older ages, but also shows considerable sex bias
(13, 14). Our own recent work demonstrated an association of
CMV infection with increased aortic stiffness in healthy, White
British older males (15). Although confirmation of these findings
in populations of different genetic backgrounds and social
circumstances is pending, our findings suggest a potentially
very important effect of biological sex on CMV-induced
immunopathology. However, despite some inroads, detailed
knowledge of sex-related differences in CMV-associated
immunity and immunopathology is lacking. A number of
studies have established that CMV infection biases theorg 2differentiation of the overall T-cell repertoire (2, 3, 6), however,
it is still unclear to what extent CMV-specific T-cells may
account for this effect. The Berlin Aging Study II (BASE-II)
showed that both age and CMV infection drive T-cell
differentiation, in both the CD4 and CD8 compartments, with
men accumulating higher frequencies of terminally differentiated
CD57+ CD8 T-cells. These cells are strongly associated with
CMV infection and have high cytotoxic potential (3). Overall,
older people had significantly higher proportions of late-
differentiated TEMRA cells (T effector memory cells re-
expressing CD45RA) among both men and women, but,
interestingly, these were exclusively accounted for by CMV+
subjects. Our own recent study on vascular stiffness also
suggested a stronger effect of CMV on memory T-cell
differentiation in men than in women, which could be one
possible explanation for increased vascular stiffness in CMV+
older men (15).
To our knowledge, the only published study on sex differences
with respect to CMV-antigen specific T-cell responses dates back
to 2004 (16). It showed that the in vitro CD4 T-cell response to a
CMV virus lysate was dominated by IFN-g and that women
exhibited higher levels of IL-2, IL-2-secreting cells, and
proliferation than men, suggesting that women react more
strongly to CMV than men. Since T-cells are the mainstay of
CMV-specific immunity, it is surprising that such differences
have not been explored in more detail since. In this study, we use
overlapping peptide pools for T-cell stimulation rather than a
virus lysate. This has a number of advantages, not least the fact
that both CD4 and CD8 T-cells can be stimulated efficiently (17,
18). A landmark study on CMV-specific T-cell immunity
published in 2005 showed that this approach is very powerful
(19). In that study CD4 and CD8 T-cell responses to 213 different
CMV proteins (ORFs) were tested in 33 adults of different ages
and biogeographical ancestries. This historic dataset was later
reanalyzed to gain insight into the variability of CMV-specific T-
cell immunity in different individuals (20), but the cohort was
too small to robustly address sex differences. Our current dataset,
however, is ideally suited for this purpose; the population of
n=94 individuals of at least 60 years of age is evenly split into
women and men, which ensures not only that the effects of CMV
on the immune system are visible in most participants, but also
that comparisons between the sexes are statistically robust. Our
work focuses on the most important CMV target proteins in
order to highlight patterns of responsiveness, including response
size, differentiation, (poly-)functionality, and efficiency of
activation (CD3 downmodulation). This study is the first ever
to show a range of significant sex differences in CMV-specific T-
cell immunity that will help explain different immunopathologies
in women and men following CMV infection.August 2021 | Volume 12 | Article 707830
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Ethics Statement
Study approved by the UKNational Research Ethics Service (NRES)
London Centre (Reference 13/LO/1270). Written informed consent
was obtained from all participants. The study was conducted in
accordance with the Declaration of Helsinki.
Participants and Samples
Generally healthy (n=94), CMV+ older volunteers (60-94 years)
were recruited through general practices (GP) in Southern
England with help of the primary care research network
(PCRN). Individuals with previous vascular events, such as
TIA, stroke or CV complications were included if generally
well with normal physical activity. However, individuals with
advanced CV morbidity were excluded.
Inclusion criteria were: White British ethnicity and age 60
years or older; exclusion criteria were: known immunodeficiency
(including HIV infection), organ transplantation, use of
immunosuppressive or immune-modulating drugs within the
last year (excluding acetylsalicylic acid ≤ 100mg/day), cancer or
treatment for cancer within the previous 5 years, insulin
dependent diabetes, moderate or advanced renal failure, liver
disease, endocrine disorders (except corrected thyroid
dysfunction), manifest autoimmune disease, dementia/mental
incompetence, known alcoholism or other drug abuse, acute
infection or illness in the last 4 weeks, raised body temperature
(>37.5°C), moderate or severe heart failure (NYHA III or IV),
inability to lie flat. Individuals with typical, age-related
cardiovascular morbidity were not excluded.
Participant Data and Sample Collection
Peripheral blood from each subject was collected by
venipuncture in sodium Heparin-containing tubes. PBMCs
were isolated after collection using Ficoll-Hypaque density
gradient centrifugation (Sigma Aldrich, Steinheim, Germany).Frontiers in Immunology | www.frontiersin.org 3CMV Serology
CMV immunoglobulin G (IgG) serology (Architect CMV IgG,
Abbot, Maidenhead, UK) was performed at the Brighton and
Sussex University Hospital Trust (BSUHT) virology laboratory.
CMV Peptides
Overlapping peptide pools representing 16 CMV proteins
arranged in 14 pools (Table 1) were used in T-cell stimulation
assays [for details see Supplementary Material and (15)].
CMV Reactivity of T-Cells
PBMCs were stimulated overnight (16h) with CMV peptide
pools. The following morning cells, were stained and acquired
by flow-cytometry. Phenotype markers included CD3, CD4,
CD8, CD45RA and CCR7 (surface staining). Activation
markers included IL-2, TNF, and IFN-g (ICS). The gating
strategy is shown in Figure S1. Responses were considered
positive when a clustered population of activated cells was
identified (visual inspection) above 0.01% of CD4 or CD8 T-
cells after background subtraction from the unstimulated sample.
For more details, see Supplementary Material and (15).
T-Cell Counts
T-cell counts per nanoliter (nL) of blood were determined using
a dual platform approach. White blood counts were obtained
from the routine clinical laboratory using a Sysmex counter
(Sysmex, UK). Using fresh whole blood, CD45+ cells (white
blood cells) were gated as well as CD4 and CD8 T-cells (using
CD3, CD4, and CD8). CD4 and CD8 T-cells per nL of blood
were determined in two steps. First, the proportion of CD4 and
CD8 T-cells among WBC was determined by dividing the CD4
and CD8 T-cell counts in the CD45+ gate (absolute event count)
by the CD45+ gate count (absolute event count). This proportion
was then multiplied with the WBC. Absolute CD4 and CD8
T-cell counts were available in 47 men (100%) and 42
women (89.4%).TABLE 1 | CMV protein-covering peptide-pools used for T-cell stimulationa.
Pool CMV Protein(s) Kinetic classc (21) No. of Peptides
1 none n.a. n.a.
2 UL55 L 224
3 UL83 (‘pp65’) L 138
4 UL86 E-L 340
5 UL122 (‘IE2’) IE (L) 120
6 UL123 (‘IE1’) IE 143
7 UL153 L 67
8 UL32 L 260
9 UL28 L 92
10 UL48Ab L 281
11 UL48Bb L 281
12 US3 IE 44
13 UL151& UL82 unclassified & L 219 (82 &137)
14 UL94 & US29 L&E-L 197 (84 &113)
15 US24 & UL36 E&E(IE) 240 (123 &117)
16 SEB (positive control)August 2021 | Volume 12aA panel of 19 CMV protein-spanning peptide pools was previously shown to correlate highly with the CD4 and CD8 T-cell response against 203 tested CMV proteins (19). The original
panel contained UL99, UL103, and US32 in addition, but were left out here since responses were absent in >100 White British people. bUL48 was divided into two pools (UL48A and
UL48B), however, results were combined with respect to determining T-cell reactivity. cIE, immediate early; E, early; L, late; n.a., not applicable.| Article 707830
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The raw data obtained from Flow Cytometry (FlowJo v9.6) was
processed by a php script running PHP Version 7.1.33. The data
processing involves the computation of percentage counts for
each patient and tube, background subtraction, sums of subset
counts for each patient (and type of subset), and the production
of FunkyCells compatible data files, containing percentages for
each T-cell memory subset.
HLA Typing
HLA-typing was performed at the Institute for Transfusion
Medicine, HannoverMedical School, Hannover/Germany [see (10)].
Polyfunctionality Index and
Differentiation Score
Polyfunctionality analysis was performed using FunkyCells software
(www.Funkycells.com). The polyfunctionality index was described
previously (22). Of note, here we performed the analysis on antigen-
specific T-cells by gating on cells secreting at least one cytokine.




where k is the total number of functions studied, Fi is the frequency
(%) of cells performing i functions.
The differentiation profiles of T-cells were based on CD45RA
and CCR7 expression. The four differentiation states were identified
as Naive (i=0, CD45RA+CCR7+), Central Memory (i=1, CD45RA-
CCR7+), Effector Memory (i=2, CD45RA-CCR7+) and Revertant
(i=3, CD45RA+CCR7-).




Sidak’s (biological sex) and Tukey’s (CMV proteins) multiple
comparison correction were applied for multiple end-point
correction with respect to gender and protein-specific T-cell
reactivity, and gender and protein-specific CD3 downregulation
in 2-way ANOVA analyses.
Charts
The 3D bar charts were created by a Python program running
Python version 3.3.7. The following python libraries were used:
numpy, pandas, matplotlib, math, and scipy.stats. Scatter pie
charts were generated using R (version 3.6.2) (23) and the
packages ggplot2 (24) and scatterpie (25).RESULTS
Global Distribution of CMV Protein
Reactivity Does Not Differ Between
Males and Females
We recently recruited a cohort of 108 CMV seropositive and 101
CMV seronegative individuals between 60 and 93 years of ageFrontiers in Immunology | www.frontiersin.org 4(10, 15). The present analysis comprises 94 CMV+ participants,
in whom T-cell responses to CMV were measured including 47
women and 47 men of very similar age distribution (70.7 ± 6.5
years and 71.1 ± 8.2 years, respectively, mean ± SD). For testing
T-cell reactivity to CMV, we used overlapping peptide pools
covering 16 CMV proteins arranged in 14 stimulation pools
(Table 1). The 16 proteins were selected from a group of 19
proteins previously identified to correlate highly with the T-cell
response to all CMV proteins (19), but three proteins previously
not inducing a single response in >100 White British individuals
were omitted (26). Note that the selected proteins cover different
kinetic classes (Table 1), which are being considered as part of
the analysis. The division of proteins by kinetic classes accounts
for the fact that different CMV proteins occur at different times
after CMV reactivation. More precisely, those detectable at the
earliest times are referred to as ‘immediate early’ (IE) and those
that appear last are part of the virion at late (L) times. Some
proteins appear in between, i.e., at early (E) and early-late (E-L)
times (21, 27).
For the representation of protein-specific reactivity, the
responses to two pools including UL48 peptides (UL48A and
UL48B) were combined (Figure 1). We first analyzed CD4 and
CD8 T-cell responses to each pool with respect to the three
cytokines measured (IL-2, TNF, IFN-g). This was done cytokine
by cytokine and in combination. (Figure S1, gating strategy).
Logical combination of two possible states for each cytokine (i.e.,
IL-2+ or IL-2-, TNF+ or TNF-, IFN-g+ or IFN-g-) resulted in
seven non-overlapping (Boolean) subsets of cells with one or
more positive markers (Figure 1C, 1-7 hereafter), and one non-
activated all-negative subset (IL-2-/TNF-/IFN-g-). Individuals
were considered ‘reactive’ to a pool if the percentage of
activated events was equal to or larger than 0.01% (1/10,000)
within CD4 and CD8 T-cells. After ranking the responses
according to the number of individuals reacting to each CMV
protein pool, the top five CD4 T-cell targets (UL83, UL55, US24
& UL36, UL86 and UL32) and top two CD8 T-cell targets (UL83
and UL123) were the same as in our previous study (28), but the
order deviated slightly for the less dominant proteins
(Figure 1A). The number and frequency distribution of
protein target-specific T-cell responses were very similar in the
two sexes (Figure 1B). For CD4 T-cells the median number of
recognized proteins was 9 (IQR 7-11) in women and 8 (IQR 6-
10) in men, the difference being borderline significant (p=0.082),
for CD8 T-cells it was 6 (IQR 4-9) in both groups.
Theoretically, CMV protein recognition by T-cells should be
affected by HLA-type. Peptides arising from a given CMV target
protein will bind to some, but not all HLA-alleles. Individuals
possessing the right alleles are, therefore, more likely to respond to
these peptides than other individuals. All the participants of this
study were White British and no significant difference between men
and women in terms of target protein recognition was observed
(Figure 1B). Regarding protein-specific response size, we observed a
statistically significant difference between men and women in the
size of the CD8 T-cell response to UL123 (IE-1) andUL153 proteins
(p ≤ 0.05/14, i.e., p ≤ 0.0036, Bonferroni correction for 14
endpoints), which could have been caused by differences in theAugust 2021 | Volume 12 | Article 707830
Reus et al. Sex Differences in CMV-Specific Immunityfrequencies of one or more class-I HLA-alleles. HLA-typing (2-
field-code) was available for only 28 women and 25 men. The
difference with respect to these protein-specific responses, however,
was not significant among the HLA-typed individuals, so that a
possible effect of HLA-type on these responses could not be
explored. As would be expected in a group of this size (given the
vast polymorphism of the HLA-locus), HLA-alleles were not
distributed completely evenly between women and men. Among
the 53 HLA-typed participants, a total of 109 class-I and class-II
HLA-alleles were present. Using the CHI2 test (Fisher’s exact test),
we identified one single (class-II) HLA allele that was distributed
significantly differently between the sexes at the p ≤ 0.05 level
(HLA-DQB1*03:01, p=0.02, CHI2 test). Multiple end-point
correction, however, would reduce the significance level to p ≤
0.05/109, i.e., p≤0.00046. No allele difference between the sexes was
significant at that level. On the whole, the number of HLA-typedFrontiers in Immunology | www.frontiersin.org 5individuals was too small to allow a rigorous analysis of the effect of
HLA-type on protein-specific T-cell response sizes in women
and men.
Next, the distribution of functional subsets 1 to 7 across all
CMV proteins by size (Figure 1C) was determined either as
weighted (contribution is proportional to protein-specific
response sizes) or unweighted (all responses make the same
contribution). No significant sex differences in functional subset
distribution were detected at this level.
Among Men, Response Profiles Are More
Focused on Fewer Dominant Responses
Than in Women
To explore potential sex differences, we conducted an in-depth
analysis of T-cell responsiveness to a range of known and
dominant target proteins (Table 1) using ex vivo stimulationA B
C
FIGURE 1 | Reactivity of CD4 and CD8 T-cells against dominant CMV proteins. (A) The indicated proteins (overlapping peptide pools) were used for PBMC
stimulation. Responses (IL-2, TNF, or IFN-g) equal to or higher than 0.01% (1/10,000) of the reference population (CD4 or CD8) were included. The graph shows the
number of individuals recognising the indicated CMV protein pools within the entire cohort (n=94). (B) The graph shows the number of recognised proteins per
individual (x-axis) in females (right panels, n=47) and males (left panels, n=47), respectively. (C) Heatmaps show the frequency distribution of functional Subsets 1 to
7 (respectively: IL-2+/TNF+/IFN-g+; IL-2+/TNF+/IFN-g-; IL-2+/TNF-/IFN-g+; IL-2+/TNF-/IFN-g-; IL-2-/TNF+/IFN-g+; IL-2-/TNF+/IFN-g-; and IL-2-/TNF-/IFN-g+, right
table) within CD4 and CD8 T-cells, in females and in males. The heatmaps on the left show the contribution of each subset after weighing this relatively to the overall
response size, while the heatmaps on the right show the unweighted contribution (not normalised for the response size).August 2021 | Volume 12 | Article 707830
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whether the overall CMV-specific T-cell response size differed
between the sexes. This was achieved by summing up all CMV
protein-specific responses (i) with respect to each cytokine
separately (IL-2, TNF and IFN-g) and (ii) all cytokines in
combination. Although men generally showed higher (median)
responses, no statistically significant sex differences were detected
with respect to the overall CD4 T-cell response. However, CD8 T-
cell responsesmeasured inpercent ofCD8T-cellswere significantly
bigger in men than in women with respect to TNF, IFN-g, or ‘any’
activation marker. This was also true (and included IL-2) when
considering T-cell counts per volume of blood (Table 2). Note that
for the purpose of analyzing T-cell response size, wemostly rely on
subset percentages in terms of CD4 and CD8 T-cells, which agrees
with our own previous work andmost reports in the literature. The
percentage reflects thedegreeofcommitmentof theoverall resource
(CD4 and CD8 T-cells) to certain phenotypic/functional subsets,
making them amenable to comparison. We have, however, also
performed analyses in terms of cell counts per volume of blood.
Overall, the two measures show a very high correlation (Figure S2
and Table S1).
We then investigated the question whether the size of the
summated CMV-specific T-cell response correlated with the
number of recognized CMV proteins in each individual. There was
a weak, but statistically significant correlation among CD4 (R=0.258,
p=0.012), but not CD8 T-cells (Table S2). The lack of a stronger
correlation between these parameters reflected that the contribution
of individual CMV protein-specific responses to overall response size
was clearly highly variable (Figures S3, S4). The UL83 and UL55-
specific responses among CD4 T-cells were significantly bigger than
other responses. IL-2+ CD4 T-cell responses were dominated by
responses to the late (L) structural target proteins, UL55, UL83, and
UL86 (Figure S3). However, in regards to TNF and IFN-g responses,
the immediate early (IE) protein-specific responses also played a
major role. US3 was slightly less frequently recognized than UL123
(IE-1) and UL122 (IE-2) (Figure 1A), yet clearly induced bigger CD4
T-cell responses (Figure S3). As previously reported (26, 28), the CD8Frontiers in Immunology | www.frontiersin.org 6T-cell response was dominated by UL83 and UL123 (Figure 1A and
Figure S3). Of note, we found that CD8 T-cell responses to UL28
were very large in some individuals, but more variable than responses
to UL83 and UL123. Essentially, the same patterns were revealed
when using cell count per volume of blood (cells/nL) instead of
percentages of CD4 or CD8 T-cells (Figure S4).
We subsequently explored which proteins showed the biggest
sex differences in response magnitude and if there were sex
differences in regards to protein immunodominance (Figure 2).
Overall, there was a clearly visible trend towards higher TNF and
IFN-g responses in men (Figure 2, heatmaps) both among CD4
and CD8 T-cells. However, using stringent multiple endpoint
correction, only the difference in the size of the IFN-g CD4 T-cell
response to the UL86 protein was statistically significant. US3-
specific CD4 T-cell responses were four to five times bigger in
men than in women, but the difference did not reach statistical
significance (Figure 2).
Interestingly, the CD4 T-cell response to UL55 differed
significantly in size from responses to multiple other CMV
proteins in men (blue) but not women (orange), underscoring the
dominance of UL55 as CD4 T-cell target, particularly in men
(Figure 2). In particular, with respect to TNF+ and IFN-g+ CD4
T-cells, UL55-specific responses were significantly higher than
responses to nine other proteins, but only in men. Also, UL123
CD8 T-cell responses were significantly higher than three other
responses in men, but not in women. Together, these data suggest
that protein recognition is more focused on dominant proteins in
men than inwomen,withUL55,UL86 andUS3-specificCD4T-cell
responses and UL123-specific CD8 T-cell responses contributing
most to the overall larger summated response sizes.
We subsequently sought to investigate cytokine dominance in
CMV-specific T-cell responses in the two sexes. In the entire
cohort and with respect to each peptide pool, TNF and IFN-g
CD4 T-cell responses were on average higher than IL-2 responses
(p<0.0001 for each comparison), and TNF responses were bigger
than IFN-g responses (Wilcoxon test, related samples, p<0.001).
For CD8 T-cells, both TNF and IFN-g responses were biggerTABLE 2 | Overall CMV-specific response size in men and women.
Parameter All Women Men Women vs Men
Median (IQR) Median (IQR) Median (IQR) pa
CD4 IL-2 (%) 0.65 (1.34) 0.60 (0.97) 1.21 (1.73) 0.069
CD4 TNF (%) 2.42 (3.61) 2.28 (2.34) 3.08 (5.86) 0.192
CD4 IFN-g (%) 2.17 (2.78) 2.06 (2.27) 2.23 (5.39) 0.268
CD4 (any) (%) 2.84 (3.81) 2.59 (2.53) 3.27 (6.43) 0.143
CD8 IL-2 (%) 0.29 (0.52) 0.20 (0.56) 0.35 (0.63) 0.128
CD8 TNF (%) 5.55 (6.64) 3.82 (5.90) 7.26 (7.91) 0.008
CD8 IFN-g (%) 5.63 (7.26) 3.68 (6.56) 7.29 (7.22) 0.004
CD8 (any) (%) 6.53 (8.61) 4.10 (7.55) 8.61 (9.21) 0.008
CD4 IL-2 (cells/nl) 0.50 (0.98) 0.45 (0.59) 0.68 (1.11) 0.324
CD4 TNF (cells/nL) 1.74 (2.54) 1.83 (1.85) 1.70 (3.27) 0.593
CD4 IFN-g (cells/nL) 1.29 (2.04) 1.53 (1.46) 1.18 (3.13) 0.721
CD4 (any) (cells/nL) 1.95 (2.69) 2.02 (1.75) 1.92 (3.59) 0.593
CD8 IL-2 (cells/nL) 0.09 (0.25) 0.08 (0.10) 0.14 (0.29) 0.030
CD8 TNF (cells/nL) 2.00 (3.25) 1.32 (3.00) 2.91 (3.26) 0.006
CD8 IFN-g (cells/nL) 1.78 (3.43) 1.09 (2.88) 3.13 (3.40) 0.005
CD8 (any) (cells/nL) 2.39 (4.27) 1.56 (3.74) 3.61 (3.62) 0.009August 2021 | Volume 12aMann-Whitney test, not corrected for multiple endpoints. Significant values (p≤0.05) are shown in bold.| Article 707830
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the differences between TNF and IFN-g responses were not
statistically significant. All of the above differences persisted
when men and women were analyzed separately.
Sex Differences Are Reflected by CMV
Target Protein-Associated CD3
Downregulation Patterns
With respect to most tested CMV-proteins, T-cell responses
tended to be larger in men than in women (Figure 2).
Consequently, we investigated if such differences were reflected
by different degrees of activation-induced CD3 downmodulation,
which is often used as a measure of stimulation efficiency. In each
individual, CD3 downmodulation was assessed relative to the
non-activated (i.e., cytokine-negative) portion of CD4 and CD8
T-cells. Because differences in cytokine production may beFrontiers in Immunology | www.frontiersin.org 7associated with different propensities to respond to antigenic
challenge, we analyzed relative CD3 downmodulation in
each of the seven functional subsets defined by IL-2, TNF, and





This typically resulted in values between 0 and 1 (‘1’
indicating 100% downmodulation). However, in a few cases,
this ratio was negative (if the activated events had a higher MFI
than the non-responsive population) or >1 (if the MFI of the
activated T-cell population was below baseline, i.e., recorded
with a negative value).FIGURE 2 | Impact of biological sex on the CD4 and CD8 T-cell reactivity against 14 different CMV peptide pools. PBMCs from males (n=47) and females (n=47)
were stimulated with CMV peptide pools; responses below the 1/10,000 threshold were excluded (grey shaded area of each plot). Heatmaps represent response
size in males (M) and females (F). As indicated in the scale, darker shades of red represent large responses, while darker shades of blue correspond to low response
frequencies. Scatter plots show the frequencies of CD4 and CD8 T-cells responding to the indicated CMV proteins in males (blue empty triangles, M) and females
(orange empty circles, F). Error bars show median and interquartile range. Statistical differences in response sizes with respect to different CMV protein were
assessed in 2-way ANOVA (addressing both the effect of ‘sex’ and ‘CMV protein’ on the size of the cytokine response, Table S3) followed by multiple end-point
correction. Differences between proteins within males and females are shown by blue and orange lines, respectively, and differences between males and females by
black lines. Significance levels are: *p ≤ 0.05; **p ≤ 0.005; ***p ≤ 0.0005; ****p ≤ 0.0001.August 2021 | Volume 12 | Article 707830
Reus et al. Sex Differences in CMV-Specific ImmunityInterestingly, CD3 downregulation varied significantly between
the seven functional subsets in regards to each protein, but also the
responses to different proteins. It also varied between women and
men (Figures 3 and S5, S6). Functional subset 5 (IL-2-/TNF
+/IFN-g+, ‘Sub5’) showed the biggest CD3 downmodulation of all
subsets both in CD4 and CD8 T-cells (Figure S5). CD3
downmodulation in Sub5 was frequently close to 100% in CD4
T-cells but somewhat less often in CD8 T-cells. The heatmaps in
Figure S5 show a tendency towards lesser CD3 downmodulation
in Sub5 in men than in women (dominance of red over green,
Figure S5). CD3 downmodulation of Sub5 among UL28 and
UL48A-specific CD4 T-cells was weaker than among CD4 T-cells
specific to other proteins. With respect to CD8 T-cells, UL83
showing the highest levels of downregulation in both sexes,
followed by UL55 and US3. No significant differences were
elicited but, surprisingly, CD3 downmodulation overall was
weaker in the CD8 T-cells (Figure S5).Frontiers in Immunology | www.frontiersin.org 8Next, in order to establish if there was a hierarchy of CD3
downmodulation across the functional subsets, we standardized
CD3 downmodulation across all subsets to the degree of CD3
downmodulation found in Sub5, which was the most
downmodulated subset (i.e., the level of CD3 downmodulation
of each subset was divided by that of Sub5) (Figures 3 and S6).
Relative CD3 downmodulation for each subset was hence
between 0 and 1 with a very small number of exceptions in
individuals where a subset other than Sub5 showed the strongest
CD3 downmodulation (Figures 3 and S6).
With respect to CD4 T-cells (Figure 3), Sub1 showed a degree
of CD3 downmodulation similar to Sub5 (values close to 1, in
general). In regards to the most immunodominant proteins,
UL55, UL83 and UL86 (Figure 2), CD3 downmodulation was
high in virtually all functional CD4 subsets in both men and
women (Figure 3 and S6). In CD8 T-cells, interestingly, CD3
downregulation across the functional subsets was less consistentFIGURE 3 | CD3 downregulation takes place to different degrees in different functional CD4 T-cell subsets and reveals sex differences in regards to select proteins.
PBMCs from men (n=47) and females (n=47) were stimulated with specific CMV-protein peptide mixes and processed for intracellular cytokine staining, excluding
responses below the 1/10,000 threshold. Levels of CD3 downregulation in functional subsets (Sub1 through Sub7) were standardized relative to the downregulation
in Sub5. Heatmaps show CD3 downmodulation in males (M) compared with females (F). Darker shades of red represent low and darker shades of green high CD3
downmodulation. Scatter plots show CD3 downregulation in males (blue triangles) and females (orange circles). Error bars show median and interquartile range.
Statistically significant differences (i) between sexes are indicated by black lines and (ii) within sexes between proteins by blue and orange lines for men and women,
respectively. Statistical significance was determined by 2-way ANOVA followed by multiple end-point correction. Significance levels are *P ≤ 0.05; **P ≤ 0.005; ***P ≤
0.001; ****P ≤ 0.0001.August 2021 | Volume 12 | Article 707830
Reus et al. Sex Differences in CMV-Specific Immunityand showed more heterogeneity across different target proteins
(Figures S5 and S6). Table S4 shows p-values for differences in
CD3 downmodulation between the functional subsets as well as
between the sexes. These results agree with the sex differences
reported in the previous sections. Generally, sex differences were
more visible in CD4 than in CD8 T-cells. In men the CMV-
specific immune response appeared more polarized towards
dominant targets than in women.
Men Accumulate More CMV-Specific CD4
and CD8 Memory T-Cells Than Women
Wewondered whether the biological sex differences detected above in
cytokine responses were mirrored in the distribution of canonical
peripheral blood T-cell subsets. The surface markers C-C chemokine
receptor 7 (CCR7) and CD45RA were used to identify canonical T-
cell ‘memory subsets’ including naïve/naïve-like T-cells (CCR7+
CD45RA+, Na), central memory (CCR7+CD45RA-, CM), effector
memory (CCR7-CD45RA-, EM), and revertant memory T-cell
subsets (CCR7-CD45RA+, Rv) (Figure S1) (15). Of note, the
‘naïve’ phenotype will include a variable and generally smallFrontiers in Immunology | www.frontiersin.org 9number of T-cells that are antigen experienced, but exhibit a
phenotype similar to that of naïve cells, referred to as naïve-like
cells (Na). The distribution of these four subsets among CMV-
reactive T-cells was analyzed in women and men with respect to
each protein/protein-combination pair (Figure S7) and the overall
distribution (Figure 4).
We initially examined differences in the proportions of all
memory subsets among CMV-specific T-cells, which may identify
changes in response composition between the sexes (Figure 4A).
Importantly, to generate these diagrams, the percentages of each
respective subset in each individual were first added up across all
CMV proteins (top), immediate-early/early proteins (IE/E,
middle), and early-late/late proteins (E-L/L, bottom) and then the
sums were normalized to 100% for representation in the pie charts.
Larger responses to some proteins, therefore, have a stronger effect
on these pie charts than smaller responses and hence have more
weight; we refer to these charts as ‘weighted’ (averaging the
proportions across the different proteins in the first step, by
contrast, would give each protein the same weight). Regarding all
CMV-proteins together, the memory subset composition of CD4A B C
FIGURE 4 | Distribution of protein-specific T-cells across canonical blood T-cell subsets by protein kinetic class. CMV-specific T-cells (any activation marker) were
analyzed in regards to memory subset composition including naïve-like/stem-cell memory (Na, CCR7+CD45RA+, green), central memory, (CM, CCR7+CD45RA-,
yellow), effector memory (EM, CCR7-CD45RA-, orange) and revertant memory (Rv, CCR7-CD45RA+, red). (A) Pie charts show weighted average percentages of
memory T-cell subsets (composition). Top, middle, and bottom panels show all CMV-protein reactive T-cells, IE/E-protein-and E-L/L-protein-specific T-cells,
respectively. Weighted percentages were obtained by adding up responder frequency for all selected proteins, and then the sums for each subset were normalized
to 100%. (B) Stacked bar charts show non-normalized CD4 or CD8 T-cell subset percentages added up across all CMV proteins, IE/E and E-L/L proteins,
visualizing overall subset size differences between men and women. (C) Stacked bar charts show non-normalized CD4 or CD8 T-cell counts/nL of blood added up
across all CMV proteins, IE/E and E-L/L proteins, providing an alternative visualization of subset size differences between men and women. p-values indicate
significant (p ≤ 0.05) differences between females and males.August 2021 | Volume 12 | Article 707830
Reus et al. Sex Differences in CMV-Specific ImmunityT-cell responses did not significantly differ between women and
men. With respect to CD8 T-cells, however, the Na and CM
compartments were significantly larger in women than in men
(Figure 4A, top). Significant sex differences were also found in
regards to IE/E-specific CMCD4 T-cells, Na and CMCD8 T-cells,
and E-L/L-specific Na CD8 T-cells (Figure 4A, middle and
bottom). These results suggest that the proportions of the Na
and/or CM CD8 T-cell (less differentiated) compartments in men
were generally smaller. Figure 4B shows memory subset
frequencies (summed percentages) in terms of CD4 and CD8 T-
cells rather than response composition. With respect to the overall
frequencies of CMV-specific peripheral T-cells (top), EM CD4 T-
cells (p=0.045) as well as EM (p=0.014) and Rv (p=0.011) CD8 T-
cellswere significantly larger inmen thanwomen. In regards to IE/E
protein-specific T-cells (middle), men showed significantly more
EM (p=0.005) and Rv (p=0.001) CD4 T-cells and, in addition, Rv
(p=0.028) CD8 T-cells. Regarding E-L/L proteins (bottom), men
had higher EM (p=0.016) andRv (p=0.037)CD8T-cells. Figure 4C
confirms the identified sex differences showing, however, median
counts per volume of blood (cells/nL), instead of percentages. The
RvCD8T-cell subset in particular was clearly bigger inmen than in
women, for example, with respect to E-L/L proteins it was 3.7 timesFrontiers in Immunology | www.frontiersin.org 10bigger inmen (Table 3). On the whole, when considering response
size both in terms of percentages and counts per volume of blood,
significant sex differences became apparent, particularly regarding
the sizes of the EM and/or Rv compartments among CD4 and CD8
T-cells. EM and RvCD4 T-cell responses to IE/E as well as EM and
Rv CD8 T-cell responses to E-L/L proteins were between two- and
threefold higher in men than in women (Table 3).
The Amount of Cytokine Produced by
CMV-Specific T-Cells Is Higher in Men
Than in Women
Inaddition to response size,wealso examined theoverall IL-2,TNF,
IFN-g secretion ‘potential’ of CMV-specific CD4 and CD8 T-cells.
This was done in order to explore if certain proteins had more
intrinsic inflammatory potential than others and to elicit additional
potential differences between men and women. Note that, at the
single cell level, the mean fluorescence intensity (MFI) of the
cytokine detection antibody directly correlates with the amount of
intracellular cytokine. However, at the population level, the average
MFI of CMV protein-specific responses does not provide a good
measure of cytokine production unless the number of cells
producing the cytokine is taken into account. By multiplying theTABLE 3 | Biological sex differences in memory subset size and distribution.
Women Men Women/Men
Median (IQR) Median (IQR) Ratio P
Na CD4 IE/E (%) 0.03 (0.06) 0.06 (0.09) 0.57 n.s.
CM CD4 IE/E (%) 0.03 (0.05) 0.03 (0.04) 0.92 n.s.
EM CD4 IE/E (%) 0.18 (0.28) 0.37 (1.16) 0.49 0.005
Rv CD4 IE/E (%) 0.01 (0.03) 0.05 (0.15) 0.32 0.001
Na CD8 IE/E (%) 0.03 (0.07) 0.03 (0.05) 0.90 n.s.
CM CD8 IE/E (%) 0.01 (0.04) 0.01 (0.03) 0.99 n.s.
EM CD8 IE/E (%) 0.32 (0.62) 0.37 (0.9) 0.88 n.s.
Rv CD8 IE/E (%) 0.68 (1.09) 1.24 (2.48) 0.54 0.028
Na CD4 E-L/L (%) 0.19 (0.35) 0.28 (0.61) 0.70 n.s.
CM CD4 E-L/L (%) 0.14 (0.16) 0.11 (0.22) 1.19 n.s.
EM CD4 E-L/L (%) 0.85 (1.73) 1.34 (2.67) 0.64 n.s.
Rv CD4 E-L/L (%) 0.17 (0.34) 0.14 (0.65) 1.25 n.s.
Na CD8 E-L/L (%) 0.13 (0.39) 0.13 (0.3) 1.01 n.s.
CM CD8 E-L/L (%) 0.02 (0.03) 0.03 (0.04) 0.75 n.s.
EM CD8 E-L/L (%) 0.34 (1.01) 0.89 (1.42) 0.39 0.016
Rv CD8 E-L/L (%) 0.79 (3.85) 1.88 (4.15) 0.42 0.037
Na CD4 IE/E (cells/nL) 0.02 (0.04) 0.04 (0.06) 0.61 n.s.
CM CD4 IE/E (cells/nL) 0.02 (0.04) 0.02 (0.03) 1.18 n.s.
EM CD4 IE/E (cells/nL) 0.13 (0.19) 0.25 (0.56) 0.50 0.038
Rv CD4 IE/E (cells/nL) 0.01 (0.02) 0.04 (0.08) 0.36 0.010
Na CD8 IE/E (cells/nL) 0.02 (0.02) 0.01 (0.03) 1.62 n.s.
CM CD8 IE/E (cells/nL) 0 (0.02) 0.01 (0.01) 0.82 n.s.
EM CD8 IE/E (cells/nL) 0.13 (0.25) 0.15 (0.44) 0.87 n.s.
Rv CD8 IE/E (cells/nL) 0.21 (0.69) 0.4 (1.14) 0.52 0.029
Na CD4 E-L/L (cells/nL) 0.16 (0.26) 0.19 (0.28) 0.86 n.s.
CM CD4 E-L/L (cells/nL) 0.11 (0.14) 0.09 (0.13) 1.26 n.s.
EM CD4 E-L/L (cells/nL) 0.65 (1.32) 0.82 (1.97) 0.80 n.s.
Na CD4 E-L/L (cells/nL) 0.12 (0.28) 0.08 (0.26) 1.50 n.s.
Rv CD8 E-L/L (cells/nL) 0.06 (0.1) 0.07 (0.13) 0.88 n.s.
CM CD8 E-L/L (cells/nL) 0.01 (0.01) 0.01 (0.02) 0.75 n.s.
EM CD8 E-L/L (cells/nL) 0.14 (0.25) 0.45 (0.69) 0.31 0.010
Rv CD8 E-L/L (cells/nL) 0.28 (1.62) 1.02 (2.06) 0.27 0.032August 2021 | Volume 12 | Article 7Statistical significances (p ≤ 0.05) are shown in bold.
n.s., non-significant.07830
Reus et al. Sex Differences in CMV-Specific Immunitycell number (percentage of reference population) and MFI, a
surrogate for the amount of produced cytokine can be calculated
that is sometimes referred to as ‘integrated MFI’ (iMFI) (29).
We, therefore, used the iMFI to compare responses between
women and men in addition to response size alone. Also note that
with respect to cytokine production, the MFI of different protein-
specific responses cannot reasonably be added up in order to
summarize the amount of cytokine produced overall. Because the
iMFI is a surrogate for cytokine amount, however, it is permissible
(and makes sense, mathematically) to add iMFIs across responses.
This allows for the computation of cytokine production in response
to several proteins. Table 4 shows that, with respect to CD4 and
CD8 T-cells and responses to all CMV proteins, the iMFI for TNF
and IFN-g tends to be higher in men than in women. These
differences were statistically significant for CD8 T-cells only.
CMV Reactivation Responses Are Bigger
in Men and Associate With Bigger E-L/L
Responses, But Not Vice Versa
CMV reactivation is a frequent event in CMV-infected people
and thought to be probably the main driver of CMV-specific T-
cell expansions (30). As a result, CMV reactivation is also likely
to drive differences in CMV-specific T-cell responses between
women and men. Accordingly, we examined differences between
men and women regarding proteins whose expression is related
to different times after activation. We hypothesized that proteins
produced at immediate early and early times may have a bigger
impact of shaping T-cell immunity than those produced later
and that they may have different impact in women and men. We,
therefore, calculated the median response iMFI (IL-2, TNF and
IFN-g) for all pools containing IE/E proteins (UL122, UL123,
US3, US24&UL36) as well as E-L/L proteins (UL55, UL83, UL32,
UL28, UL48, UL151&UL83, UL94&US29) and compared these
between men and women (Figure 5A). Additionally, summated
response sizes with respect to the same proteins (median) were
compared between men and women (Figure 5B). The lower
panel of Figure 5B shows counts per volume of blood, essentially
confirming the results obtained with percentages. With respect to
CD4 T-cells (Figure 5A, left), the median iMFI of the IL-2, TNF,
and IFN-g responses to IE/E proteins (top) was significantly
higher in men than in women, as well as the iMFI of the E-L/L
protein-specific IL-2 response (bottom). Regarding CD8 T-cells
(Figure 5A, right), the median iMFI of the TNF response to IE/E
proteins (top) as well as the median iMFI of IL-2, TNF, and
IFN-g responses to E-L/L proteins (bottom) were all significantly
higher in men than in women. At the level of response sizes, CD4Frontiers in Immunology | www.frontiersin.org 11T-cells response to IE/E and E-L/L proteins and CD8 T-cells
response to E-L/L proteins were higher in men compared with
women (Figure 5B). Interestingly, there was a moderate association
between the size of the CD4 T-cell response to IE/E proteins and
that to E-L/L proteins (any cytokine, R=0.325, p=0.003).
We also investigated if there was an effect of the frequently
reactivated responses to IE/E proteins on the response to any
other proteins, potentially indicating that even incomplete
reactivation would push all CMV-specific responses to a more
differentiated phenotype. We, therefore, examined if the cytokine
iMFIs of responses to IE/E (compared with E-L/L) proteins were
associated with IE/E and E-L/L overall response sizes. For CD4
and CD8 T-cells we ran bivariate correlations between iMFI of
IL-2, TNF, and IFN-g responses to any CMV protein (14 pools)
and the size of the responses directed against IE/E and E-L/L
antigens (Figure 6). Note that correlations between the iMFI of
IE/E protein-specific response with the overall size of the
response to IE/E proteins would be expected as the iMFI as
such incorporates the size of the response. However, a
correlation of the iMFI of IE/E protein-specific responses and
the size or iMFI of E-L/L protein specific responses would not be
expected, unless reactivation (mostly marked by responses to IE/
E protein-antigens) were to somehow enhance E-L/L-driven
responses. Weak-to-moderate, yet significant, positive
associations between the iMFIs (IL2, TNF and IFN-g) of IE/E
protein-specific CD4 T-cell responses and the size of the E-L/L
protein specific CD4 T-cell response were found (Figure 6; see
inset tables). This effect was not identified in CD8 T-cells,
indicating that reactivation might have a stronger overall effect
on the size of the CD4 T-cell response.
Associations of Polyfunctionality With
T-Cell Differentiation Do Not Differ
Between Women and Men
In order to analyze associations of T-cell differentiation and
polyfunctionality, we used the previously described
polyfunctionality index (PI) (22), which allows one to summarize
the composition of each T-cell response in terms of non-overlapping,
functionalBoolean subsets as a single number.The advantageof using
this index is that polyfunctionality becomes a continuous variable that
can be correlated with other parameters, for example, response size.
We previously reported that, contrary to common belief,
polyfunctionality is increased in large CMV-specific responses (26,
31). Here we sought to confirm this relationship and, in addition,
explore differences between men and women in regard to protein-
specific polyfunctionality, MFI/iMFI, memory differentiation andTABLE 4 | iMFI for TNF and IFN-g between biological sex groups.
Parameter Women Men p
Median (IQR) Median (IQR)
CD4 TNF 468.37 (715.33) 644.04 (1941.48) 0.228
CD4 IFN-g 70.42 (64.24) 86.26 (156.47) 0.189
CD8 TNF 546.55 (1055.63) 1299.14 (1405.64) 0.006
CD8 IFN-g 171.42 (382.69) 364.62 (414.93) 0.004August 2021 | Volume 12 | Article 7Statistical significances (p ≤ 0.05) are shown in bold07830
Reus et al. Sex Differences in CMV-Specific Immunityresponse size. For the purpose of representingmemory differentiation
in correlations, we generated a differentiation score (DSc). This score
captures the percentages of CD4 and CD8 T-cells in each of the non-
naïve compartments and assigns progressive weight to each
compartment (see Polyfunctionality Index and Differentiation Score
for a formal definition). The polyfunctionality of responses toCMV is
more homogeneous (showing a tighter cluster of pies) for someCMV
proteins (US3 and the four late proteins: UL28, UL48A, UL48B,Frontiers in Immunology | www.frontiersin.org 12UL151& IL82) than others, in bothCD4 andCD8T-cells (Figure 7).
Compared with CD4 T-cells, fewer CD8 T-cells produce IL-2,
resulting in lower PI values for CD8 (compare Figures 7A, B). Also,
the DSc is higher in CD8 than CD4 T-cells (with a DSc hardly
exceeding 0.67) because CD4 T-cells rarely reacquire CD45RA
expression (revertant cells) (Figure 4). Nevertheless, the correlation
between polyfunctionality and differentiation score is less evident in
CD8 than in CD4 T-cells, where there is a clear increase ofA
B
FIGURE 5 | The cytokine content of CMV-specific T-cell responses is higher in men than in women. In order to compare the cytokine amounts produced by CMV-
specific T-cells in men and women the percentage (in terms of CD4 or CD8 T-cells) of each cytokine response was multiplied by the MFI to generate the ‘integrated
MFI’ (iMFI), for CD4 and CD8 T-cells. Responses were grouped by adding up the iMFI of responses to IE/E proteins (UL122, UL123, US3, US24&UL36), more likely
to reflect CMV reactivation, and those to E-L/L proteins (UL55, UL83, UL32, UL28, UL48, UL151&UL83, UL94&US29). (A) Box plots show the median iMFIs for
each cytokine response to IE/E (top) or E-L/L proteins (bottom) by CD4 (left) and CD8 (right) T-cells. (B) Box plots show the median of the summed frequencies or
counts (cells/nL) of CD4 (left) and CD8 (right) T-cells responding to IE/E and E-L/L proteins. Box plots show median and interquartile range, outlier limits (whiskers,
LQ-1.5*IQR, UQ+1.5*IQR), outliers (o). Within each graph, left and right boxes show responses in females and males, respectively.August 2021 | Volume 12 | Article 707830
Reus et al. Sex Differences in CMV-Specific Immunitypolyfunctionality with higher differentiation (Figure 7A). Of note,
thePI tends to rise alongwith theDScuntil a certainpoint, afterwhich
it decreases, as most responses predominantly originate from
revertant cells (Rv, red) (e.g., UL86, UL24&UL36, UL153 and
UL48A/B in CD4 T-cells and UL55, UL28 and UL48A in CD8 T-
cells, Figure 7). This agrees with our own previously published data
comparing MFIs in different memory T-cell compartments
(previously defined by CD27 and CD45RA) (26). While no
significant sex differences were observed for CD4 and CD8 T-cell
polyfunctionality toCMV, somenon-significant trends towards lower
polyfunctionality were apparent from UL153 in women (Figure S8).
A Population View of CMV-Target
Protein-Specific T-Cell Responses
Reveals TNF-Dominated CD4 T-Cell
Responses in Men That Are Absent
in Women
In order to visualize T-cell responses as a whole in the entire
participant population, we plotted donor (x-axis) against protein
pool (y-axis), response sizes in percentages of CD4 or CD8 T-
cells (z-axis) as well as the MFI for TNF or IFN-g (color gradient
of the columns). This four-dimensional view shows a stark
difference between women and men in regards to CD4 T-cells,
in particular those producing TNF (Figures 8, 9). It illustrates an
excess of T-cell reactivity in terms of the measured cytokines in
men and in particular the presence of response outliers. Sex
differences in regards to IFN-g producing CD4 T-cells wereFrontiers in Immunology | www.frontiersin.org 13observed only in terms of response size. In CD8 T-cells sex
differences were not nearly as obvious as in CD4 T-cells
(Figure 9). The same analysis was performed using cells
counts (cell/nL) obtaining similar results (Figures S9, S10).
In CD4 T-cells, response size measured in percentage (and
cell counts) of TNF-producing cells was hence positively
correlated with the MFI of TNF (i.e., the bigger response, the
higher the MFI of TNF). However, response size measured in
percentage (and cell counts) of IFN-g-producing T-cells was
negatively associated with the MFI of IFN-g (the larger the
response, the lower the MFI of IFN-g). Table 5 shows that in
CD4 T-cells these positive and negative associations between
response size and cytokine MFI were statistically significant for
all dominant target proteins. Among CD8 T-cells the pattern was
less clear overall, although clearly the MFIs of TNF and IFN-g
were significantly positively correlated with the respective
response size in regards to several dominant responses but not
the (most dominant) response to UL83. The pattern appeared
less clear than in CD4 T-cells.DISCUSSION
Previous studies exploring the effect of biological sex on CMV-
specific immunity had shown that CMV infection affects T-cell
differentiation differently in women and men (3, 15). However,
these studies did not explore the actual CMV-specific T-cellFIGURE 6 | IE/E and E-L/L CD4 and CD8 T-cell response correlation. PBMCs from males (n=47) and females (n=47) were stimulated and processed for intracellular
cytokine staining. Thereafter, the iMFI for each cytokine was calculated. Scatter plots show the association of IE/E protein specific with E-L/L protein-specific CD4
and CD8 T-cell responses. The inset tables show the Pearson R correlation coefficient for each association comparison with the level of significance. *p ≤ 0.05;
**p ≤ 0.005.August 2021 | Volume 12 | Article 707830
Reus et al. Sex Differences in CMV-Specific Immunityresponse in much detail, let alone the response to individual
CMV proteins representing different phases of reactivation. The
present study is the first to provide a detailed analysis of sex
differences in the T-cell response to a range of dominant CMV T-
cell target proteins.
Based on a selection of CMV proteins known to represent
frequent and dominant T-cell response targets (19), we initially
explored protein recognition (i.e., presence or absence of a
response in regards to each protein in each individual) in a
recently recruited cohort of 94 CMV-seropositive individuals. As
expected, hierarchies in terms of protein recognition frequency
differed between CD4 and CD8 T-cells. However, our results
confirmed the previously identified hierarchy in an equally
White British cohort with respect to the most dominant target
proteins (26, 28). Minor differences detected in target protein
response hierarchy between the historic cohort (19) and the
present one may be related to differences in HLA-allele
frequencies, since the historic cohort was ethnically
more diverse.Frontiers in Immunology | www.frontiersin.org 14Interestingly, the numbers of protein targets recognized by
CD4 T-cells and CD8 T-cells in each individual were
significantly correlated, despite the fact that CD4 and CD8 T-
cells recognize peptides in the context of class-II and class-I
MHC, respectively. This might be explained by an
accumulation of HLA-alleles favoring CMV-peptide
recognition during evolution. The distribution of T-cell
responses in terms of recognized target proteins was very
similar in women and men.
In agreement with the literature and our own previous reports
(19, 20, 26, 28, 31), both the CD4 and CD8 T-cell compartments
make a significant contribution to the CMV-specific T-cell
response. CD4 T-cells may respond to antigens presented in
the context of class-II MHC on APCs, but also endothelial cells.
In addition, infected endothelial cells (and possibly other tissues)
produce non-infectious exosomes containing CMV proteins.
These are taken up by APCs and presented to CD4 T-cells
(32). CD8 T-cells however seem to be mainly primed by cross
presentation as CMV induces downmodulation of MHC-IA
B
FIGURE 7 | Polyfunctionality plotted versus differentiation score reveals distinct, protein-associated patterns. (A) CD4 and (B) CD8 T-cell polyfunctionality
(Polyfunctionality Index) in relation to differentiation score for each CMV protein pool stratified according to the kinetics of the antigens. CMV protein designation and
kinetic class are indicated at the top of each graph (in panels A, B). Pie charts show memory subset distributions including naive-like/stem-cell memory (Na, green),
(CM, yellow), effector memory (EM, orange), and revertant memory (Rv, red).August 2021 | Volume 12 | Article 707830
Reus et al. Sex Differences in CMV-Specific Immunitymolecules in infected cells (33). It was previously reported that
immunogenic ORFs were represented across all kinetic classes of
HCMV proteins, and it was also shown that the frequency of
T-cells specific to a given protein was proportional to the
representation of the corresponding ORF in the entire CMV
proteome (19).Frontiers in Immunology | www.frontiersin.org 15In this study, T-cell activation was identified by intracellular
IL-2, TNF, and IFN-g. This may be a limited panel, but these
cytokines are critical for T-cell proliferation and effector function.
TNF was the cytokine most frequently produced by activated CD4
T-cells, whereas among CD8 T-cells TNF and IFN-g were equally
dominant. We previously reported that the largest age-associatedFIGURE 8 | Large CD4 T-cell responses producing high levels of TNF are found preferentially in men. 3D bar charts show all individual CD4 T-cell responses to
each CMV peptide pool in the entire population (left), men alone (middle) and women alone (right). Participants are ordered by increasing median T-cell response size
from left to right with respect to the entire population. Peptide pools are ordered by increasing median response size induced from front to back, also with respect to
the entire population. Bar height corresponds to the percentage of cytokine producing CD4 T-cells, i.e., response size. Bar color corresponds to the MFI of the
measured cytokine according to the displayed scale.August 2021 | Volume 12 | Article 707830
Reus et al. Sex Differences in CMV-Specific Immunityincrease in CMV-specific T-cell responses occurred in regards to
TNF-producing CD4 T-cells (28), which is of interest in this
context, since the participants of this study were 60 years old or
older. Our previous study, however, did not explore sex differences,
but our current work clearly shows that men have overall larger T-
cell responses to CMV proteins than women with a more pro-
inflammatory CD4 T-cell component.Frontiers in Immunology | www.frontiersin.org 16The combination of the three cytokines further allowed the
division of activated T-cells into seven non-overlapping
(Boolean) functional subsets. The relative contribution of these
subsets to the overall response, as expected, differed a lot between
CD4 and CD8 T-cells, and this was clearly the effect of CD8 T-
cells not producing as much IL-2 as CD4 T-cells. The most
‘polyfunctional’ subset simultaneously producing IL-2, TNF, andFIGURE 9 | Patterns of TNF and IFN-g producing CD8 T-cells appear similar in terms of size and distribution among men and women. 3D bar charts show all
individual CD8 T-cell responses to each CMV peptide pool in the entire population (left), men alone (middle) and women alone (right). Participants are ordered by
increasing median T-cell response size from left to right with respect to the entire population. Peptide pools are ordered by increasing median response size induced
from front to back, also with respect to the entire population. Bar height corresponds to the percentage of cytokine producing CD8 T-cells, i.e., response size. Bar
color corresponds to the MFI of the measured cytokine according to the displayed scale.August 2021 | Volume 12 | Article 707830
Reus et al. Sex Differences in CMV-Specific ImmunityIFN-g was, therefore, much smaller in the CD8 T-cell
compartment. In both T-cell compartments, however, the
largest subset was generally subset 5 producing TNF and
IFN-g, but not IL-2. We found no sex difference in regards to
the distribution of these subsets.
Another way of subdividing activated T-cell subsets is by their
expressionofmarkers defining ‘canonical’memoryT-cell subsets (i.e.,
naïve/naive-like stem cell memory, central memory, effectormemory
and revertant). This allows some conclusions as to the role that each
protein plays in terms of driving T-cell memory. We analyzed the
distribution of these subsets in regards to CD4 and CD8 responses to
every single protein and also in termsof kinetic classes. Thedivisionof
proteins by their assigned kinetic classes accounts for the fact that
different CMV proteins may have more or less influence on T-cell
responsiveness, depending on their presence or absence during the
(frequent) reactivation of latent CMV infection (21, 27). IE protein
expression will dominate immediately after reactivation and, in
particular, if reactivation is abrogated and remains incomplete. The
major immediate early promoter (MIEP) regulates IE protein
expression and appears to be regulated itself by cellular chromatin
activity, an increase of which is the common endpoint of a host of
signalingpathways, particularly in inflammation (34).Memory subsetFrontiers in Immunology | www.frontiersin.org 17composition was hence analyzed across all CMV proteins but also
grouped by kinetic class, combining IE and E protein-specific
responses in one group and E-L/L protein specific responses in the
other. Responses to individual proteins varied significantly in terms of
memory subset distribution both among CD4 and CD8 T-cells.
Whereas the (normalized) composition of responses in terms of
memory subset contribution indicated that there were smaller naïve
and/orCMcontributions to theCD4andCD8T-cell response inmen,
comparing the summed responses to these subsets showed that, not
only the entire response (all memory subsets together) was bigger in
men, but that in particular the EM and/or revertant subset
contributions to responses against all CMV proteins and IE/E
proteins were significantly bigger in men than in women. So, not
only didmenhavebigger responses thanwomen, but also theEMand
Rv component of these responses appeared to contribute most to
that difference.
It is a limitation of our work that viral load was not
determined in our cohort. Previous work has shown that in
otherwise healthy older people viral load is generally negative,
however, digital droplet PCR may detect viral load in healthy
older people over 70 years of age (35). We are unable to link T-
cell responsiveness to viral loads since performing this very costlyTABLE 5 | Association of T-cell response size with cytokine MFI.
Response size in % of
reference T-cell population
CD4 T-cells % IL-2
with MFI IL-2
CD4 T-cells % TNF
with MFI TNF
CD4 T-cells % IFN-g
with MFI IFN-g
CD8 T-cells % IL-2
with MFI IL-2
CD8 T-cells % TNF
with MFI TNF
CD8 T-cells % IFN-g
with MFI IFN-g
UL555 0.028 0.358** -0.310* 0.834** -0.007 -0.220
UL83 (‘pp65’) 0.085 0.483*** -0.285** -0.168 0.111 0.161
UL86 0.006 0.577*** -0.335** 0.350 -0.035 0.283
UL122 0.029 0.763*** -0.297* -0.089 0.572** 0.409*
UL123 (‘IE-1’) -0.096 0.366** -0.168 0.009 0.353** 0.250*
UL153 -0.273 0.393 -0.269 -0.059 0.363 0.218
UL32 -0.076 0.194 -0.152 0.59*2 0.227 0.278
UL28 0.307 -0.218 -0.320 0.137 0.374** 0.360*
UL48Aa 0.242 0.183 0.014 0.062 0.520* 0.977***
UL48Ba 0.424* 0.007 -0.228 0.846** 0.432 0.253
US3 -0.153 0.533*** -0.357* -0.311 0.036 -0.268
UL151& UL82 -0.049 -0.072 -0.199 0.456* 0.516*** 0.061
UL94 & US29 -0.131 0.075 0.172 -0.151 -0.025 0.159
US24 & UL36 0.006 0.482*** -0.227 -0.068 0.519** 0.075




nL IL-2 with MFI
IL-2
CD4 T-cells cells/
nL TNF with MFI
TNF
CD4 T-cells cells/
nL IFN-g with MFI
IFN- g
CD8 T-cells cells/
nL IL-2 with MFI
IL-2
CD8 T-cells cells/
nL TNF with MFI
TNF
CD8 T-cells cells/nL
IFN- g with MFI
IFN- g
UL555 0.048 0.264* -0.337** 0.912** 0.007 -0.214
UL83 (‘pp65’) 0.175 0.501*** -0.245* -0.100 0.213 0.190
UL86 0.055 0.592*** -0.331* 0.346 0.029 0.029
UL122 0.101 0.714*** -0.249 -0.173 0.635*** 0.443*
UL123 (‘IE-1’) -0.045 0.298* -0.145 0.037 0.266 0.114
UL153 -0.316 0.394 -0.271 -0.167 0.287 0.187
UL32 -0.074 0.113 -0.102 0.038 0.284 0.211
UL28 0.447 -0.123 -0.258 0.098 0.303* 0.261
UL48Aa 0.052 0.214 0.037 0.099 0.248 0.841*
UL48Ba 0.312 0.010 -0.089 0.918** 0.560 0.351
US3 -0.106 0.636*** -0.362 -0.288 0.069 -0.216
UL151& UL82 0.037 0.060 -0.042 0.024 0.600*** 0.034
UL94 & US29 -0.115 0.004 0.452* -0.244 -0.086 0.121
US24 & UL36 0.024 0.387** -0.197 -0.022 0.568** 0.059August 2021 | VolumaA panel of 19 CMV protein-spanning peptide pools was previously shown to correlate highly with the CD4 and CD8 T-cell response against 203 tested CMV proteins (19). The original
panel contained UL99, UL103, and US32 in addition, but were left out here since responses were absent in >100 White British people. UL48 was divided into two pools (UL48A and
UL48B), however, results were combined with respect to determining T-cell reactivity. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001.
Statistical significances (p-values ≤0.05) are shown in bold.e 12 | Article 707830
Reus et al. Sex Differences in CMV-Specific Immunityassay in all participants was outside the scope of our work.
However, it is a possibility that a higher frequency of (potentially
incomplete) CMV reactivation in men might contribute to a
dominance of T-cell responsiveness to IE/E proteins. This would
need to be addressed in future studies. The possible role of
latency-associated proteins was not explored. Responses to these
proteins appear to have very different functional characteristics
than responses to lytic phase proteins (36), interestingly,
however, changes to chromatin structure induced by histone
deacetylases (HDACs) may lead to the transient expression of IE
proteins without leading to full viral reactivation. This can be
induced pharmacologically (37), but may also occur as a result of
chromatin activity during cellular activation (34). It might be
speculated that such an effect is more prominent in men.
Recent work suggests that persistent stimulation of CMV-
specific T-cells may additionally result from a continuous low-
level gene expression during latency with increasing evidence
coming from both human and mouse models (38–40). This low-
level gene expression may be involved in regulating the switch
between latency and reactivation, and in the murine infection
model appears to have random (stochastic) characteristics with a
skewing to IE transcripts at about 8 months after latent infection of
lungs (40). We speculate that increased proinflammatory cytokine
secretion in response to immune stimulation in men (41) may
increase low-level latent CMV gene expression and so contribute to
the gender difference we have observed in the present study.
T-cell polyfunctionality is thought to be related to T-cell
response efficacy after vaccination (42, 43). We used the
polyfunctionality index (22) to gauge T-cell polyfunctionality as a
compound measure allowing us to correlate it to other variables.
Our data confirms that the most differentiated subsets (Rv) have
reduced polyfunctionality, but the bulk of expanded and highly
differentiated (EM and Rv) CD4 T-cells appears to retain two or
more functions. This is particularly visible in the diagrams showing
the differentiation score versus the polyfunctionality index. It is also
in agreement with our previous report that expanded T-cells in
older ages retain polyfunctionality (26).
The combination of polyfunctionality index and differentiation
scoreobserved inT-cells responding todifferentCMVproteinsmight
reflect the role of these proteins in driving T-cell responsiveness.
Responses to some proteins showed a wider spread along the axes
than others. CD4 and CD8 T-cells responding to the UL123 protein,
for example, generally had a high differentiation score and appeared
more homogeneous in that sense than the response to US3, which
included many cells at an early stage of memory differentiation. The
T-cell response to UL83, one of the most dominant T-cell target
proteins for bothCD4 andCD8T-cells, also includedpredominantly
cells in an EM/Rv differentiation stage.
More inflammation, therefore, means more CMV reactivation.
US3 is an IE protein and appears to be the earliest protein expressed
that contributes to immune evasion. It does so by reducing the
number of mature MHC complexes in the surface of infected cells
(44, 45). Strong T-cell immunity against US3 might curtail this
mechanism of immune evasion. US3 was recognized in about 50%
of individuals with respect to CD4 T-cells (23 women and 22 men)
and in about 40% with respect to CD8 T-cells (21 men and 15
women). The response to US3 was four to five times bigger in menFrontiers in Immunology | www.frontiersin.org 18than in women, but this difference reached statistical significance
only in regards to IL-2+ CD4 T-cells. Differences with respect to the
UL122 (IE-2) and UL123 (IE-1), two other dominant IE proteins,
were not statistically significant, however there was a trend to larger
TNF and IFN-g UL123-specific CD8 T-cell responses in males.
Overall, men appeared to have bigger responses to IE and E proteins
than women. Responses to these immediate-early/early gene
products may be of particular importance in driving the size of
the T-cell immune response to CMV (44).
We also analyzed sex differences regarding the pro-
inflammatory cytokine content of CMV-specific T-cell responses.
Since we had not directly measured cytokine production in the
supernatant of stimulated cells, we used the integrated MFI (iMFI)
as a surrogate marker for the amount of cytokine produced (29, 46).
With respect to CD4 and CD8 T-cells and all CMV proteins, the
summated iMFI for TNF and IFN-g was found higher in men than
in women. The biggest sex differences in the CD4 T-cell
compartment were related to IE/E proteins and in the CD8
compartment to E-L/L proteins. A limitation of these results
might be that IE proteins are clearly overrepresented in our
selection. This selection, however, was not random, but based on
an analysis of overall protein immunodominance (19).
CD3/TCR downregulation occurs following T-cell recognition
of MHC-peptide complexes (47) and, generally, correlates with T-
cell activation and, more specifically, the strength of the initial
activation (48, 49). The extent of CD3 downmodulation varied
across the functional subsets defined by the presence or absence of
IL-2, TNF, and IFN-g. Sub1 (IL-2+/TNF+/IFN-g+) and Sub5 (IL-
2-/TNF+/IFN-g+) showed the highest relative CD3
downregulation in CD4 T cells and Sub5 in CD8 T-cells. One
benefit of CD3 downmodulation might be that, as a result of
stronger downmodulation, high avidity, highly pro-inflammatory
T-cell clones may compete less with lower avidity clones and so
avoid excessive inflammatory responses (50). This would fit, for
example, with the lesser CD3 downmodulation in men in regards
to CD4 T-cell responses to a portion of the very abundant late
protein UL48 (UL48A peptide pool) and would be commensurate
with the equally observed trend to higher TNF-production by CD4
T-cells in response to the same peptide pool in men. However, our
understanding of the biological significance of CD4 and CD8 T-cell
responses to individual CMV proteins remains limited and we are
unable to explain the majority of patterns of cytokine production
versus CD3 downmodulation that we have observed. One might
also speculate that effector T-cells that readily downregulate CD3/
TCR may not progress towards terminal differentiation. This
would favor the retention of IL-2 and TNF production, possibly
alongside IFN-g, and promote the emergence of long-lived
polyfunctional T-cells with high avidity. The exact mechanisms
of CD3/TCR downmodulation are still being debated. Beyond the
TCR signal, they are involved in costimulation/immunoregulatory
pathways [e.g., PD-1:PDL-1 (51)].CONCLUSIONS
Our work shows a number of statistically significant sex differences
with respect to CMV-specific T-cell immunity (besides a number ofAugust 2021 | Volume 12 | Article 707830
Reus et al. Sex Differences in CMV-Specific Immunitystatistically not significant, yet obvious trends).While CMV infection
has been reported to cause broad changes to the peripheral blood B-
and T-cell compartments with significant differences between
women and men, sex differences regarding CMV protein-specific
T-cells have not been widely discussed. The trends we observed all
point in the same direction, suggesting that older men have a
stronger and more inflammatory response to CMV than older
women. This may be driven by more frequent CMV reactivation
(or partial CMV reactivation) throughout life, which is suggested by
higher T-cell responses to IE/E proteins in men. These findings are
particularly relevant as CMV infection has been increasingly
associated with CVD, which also has a higher incidence in men.
Many of the differences we observed as trends would have reached
statistical significance, had we not applied stringent multiple end-
point corrections. While these remain a useful statistical safeguard
against falling for random observations, future studies are warranted
revisiting these observations. We are hoping that our work described
here will have a seminal effect and make others examine gender
differences in the adaptive immune system as we move towards a
more personalized and stratified medicine.DATA AVAILABILITY STATEMENT
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